Olmesartan 20mg and 40mg tablets represent high-quality active pharmaceutical ingredients specifically developed for hypertension treatment. Manufactured under strict quality contr...

Olmesartan 20mg and 40mg tablets represent high-quality active pharmaceutical ingredients specifically developed for hypertension treatment. Manufactured under strict quality control standards, this angiotensin II receptor blocker effectively manages blood pressure by selectively inhibiting the vasoconstrictor effects of angiotensin II. The product offers two standardized dosage options - 20mg for mild to moderate hypertension cases and 40mg for severe conditions or patients requiring higher therapeutic levels. Each production batch undergoes comprehensive quality testing including purity analysis, dissolution profiling, and stability assessments to ensure consistent performance in final pharmaceutical formulations. The API demonstrates excellent bioavailability and predictable pharmacokinetics, making it ideal for developing reliable dosing regimens that healthcare providers can trust for patient care.

Pharmaceutical manufacturers worldwide incorporate Olmesartan API into various antihypertensive drug formulations across multiple therapeutic categories. The cardiovascular medicine segment represents the primary application area, with companies developing both single-ingredient products and combination tablets that include complementary active ingredients. Hospital systems and institutional healthcare providers source bulk quantities for their medication programs, while generic drug manufacturers appreciate its cost-effectiveness for public health initiatives. Export-focused pharmaceutical companies utilize this API in products meeting international regulatory standards for markets where hypertension prevalence continues to rise significantly. The product complies with major pharmacopeial specifications including USP, EP, and IP requirements, ensuring broad regulatory acceptance across different regions and markets.

Business partners benefit from consistent supply chain reliability with maintained batch-to-batch uniformity that reduces formulation validation expenses. The product's thermal stability and extended shelf life minimize storage concerns during transportation and distribution processes. Manufacturing facilities maintain proper certifications and undergo regular quality audits, providing assurance of robust quality management systems throughout production. Established safety profiles and comprehensive clinical data support streamlined market authorization procedures across multiple regions, significantly reducing time-to-market for finished pharmaceutical products. This reliability enables manufacturers to plan production schedules with confidence and maintain consistent product availability for healthcare providers and patients.

Key Features:
- Available in standardized 20mg and 40mg dosage strengths for formulation flexibility
- Manufactured following current Good Manufacturing Practice compliance requirements
- High purity specification exceeding 99.5% with controlled impurity profiles
- Demonstrated stability performance with 36-month shelf life under recommended storage
- Complete documentation package including Certificate of Analysis and stability records

Benefits:
- Flexible dosage options enable tailored formulations for different patient needs
- Quality manufacturing standards ensure consistent product performance and reliability
- High purity levels contribute to predictable therapeutic outcomes and safety
- Extended shelf life reduces product waste and supports efficient inventory management
- Comprehensive documentation simplifies regulatory submissions and quality verification